Low Dose Midazolam versus Propofol for Conscious Sedation During Diagnostic Endoscopy for Day Case Surgery: A randomized clinical trial
DOI:
https://doi.org/10.47489/szmc.v40i2.959Keywords:
Endoscopy, Conscious Sedation, MidazolamAbstract
Background: As endoscopy is an invasive and painful procedure, it is necessary to use a suitable sedative in terms of anesthetic efficacy. There is a lack of evidence comparing the use of propofol versus midazolam for sedation in endoscopy in developing countries.
Objective: To compare low-dose midazolam versus propofol in terms of time required for achieving conscious sedation and time to recovery in patients undergoing diagnostic endoscopy for day-case surgery.
Method: The study was a randomized controlled trial. One hundred patients who met the inclusion criteria were enrolled and split into two groups of fifty each at random by computer-generated allocation sequence after providing written informed permission. Propofol was given to patients in group B, while midazolam was given to patients in group A. Endoscopy was performed after the time to conscious sedation was recorded. Following that, recovery time was noted, and as the data was non-normal in distribution, outcome measures between both groups were compared using the Mann-Whitney U test.
Results: The median age of patients in the midazolam group was 42.5 (IQR: 18) years and in the propofol group was 39 (IQR: 16.25) years. The median time to conscious sedation in the midazolam group was 2.5 (IQR: 1) minutes, and in the propofol group, it was 2 (IQR: 1) minutes. (p=0.04). The propofol group's median recovery time was 16 (IQR: 3) minutes, while the midazolam group's was 18 (IQR: 3) minutes (p < 0.001).
Conclusion: In patients who underwent diagnostic endoscopy, propofol was significantly associated with shorter time to achieve conscious sedation and recovery compared to midazolam.
References
Kim JH, Kim DH, Kim JH. Low?dose midazolam and propofol use for conscious sedation during diagnostic endoscopy. Kaohsiung J Med Sci. 2019;35(3):160-167. Doi: https://doi.org/10.1002/kjm2.12028
Han SJ, Lee TH, Park SH, Cho YS, Lee YN, Jung Y, et al. Efficacy of midazolam?versus propofol?based sedation by non?anesthesiologists during therapeutic endoscopic retrograde cholangiopancreatography in patients aged over 80 years. Dig Endosc. 2017;29(3):369-376. Doi: https://doi.org/10.1111/den.12841
Wahab EA, Hamed EF, Ahmad HS, Abdel Monem SM, Fathy T. Conscious sedation using propofol versus midazolam in cirrhotic patients during upper GI endoscopy: a comparative study. JGH Open. 2019;3(1):25-31. Doi: https://doi.org/10.1002/jgh3.12098
Lu Z, Li W, Chen H, Qian Y. Efficacy of a Dexmedetomidine–Remifentanil Combination Compared with a Midazolam–Remifentanil Combination for Conscious Sedation During Therapeutic Endoscopic Retrograde Cholangio-Pancreatography: A Prospective, Randomized, Single-Blinded Preliminary Trial. Dig Dis Sci. 2018;63(6):1633-1640. Doi: https://doi.org/10.1007/s10620-018-5034-3
Yin S, Hong J, Sha T, Chen Z, Guo Y, Li C, et al. Efficacy and tolerability of sufentanil, dexmedetomidine, or ketamine added to propofol-based sedation for gastrointestinal endoscopy in elderly patients: a prospective, randomized, controlled trial. Clin Ther. 2019;41(9):1864-1877.
Doi: https://doi.org/10.1016/j.clinthera.2019.06.011
de Almeida Delgado AA, de Moura DT, Ribeiro IB, Bazarbashi AN, Dos Santos ME, Bernardo WM, et al. Propofol vs traditional sedatives for sedation in endoscopy: A systematic review and meta-analysis. World J Gastrointest Endosc. 2019;11(12):573-576. Doi: https://doi.org/10.4253/wjge.v11.i12.573
Lee HS, Nagra N, La Selva D, Kozarek RA, Ross A, Weigel W, et al. Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate. Clin Gastroenterol Hepatol. 2021;19(1):180-188. Doi: https://doi.org/10.1016/j.cgh.2020.09.018
Popa-Ion DA, Gheonea DI, Denicu MM, Chiu?u LC. Comparative study of moderate sedation with propofol versus propofol combined with midazolam for ambulatory care digestive endoscopic procedures. Curr Health Sci J. 2022;48(3):292-302. Doi: https://doi.org/10.12865/chsj.48.03.07
Xie G, Estevez M, Heybati K, Vogt M, Smith M, Moshe C, et al. Outcomes of anesthesia-supported versus endoscopist-driven sedation modalities: a retrospective cohort study. Gastrointest Endosc. 2025;102(2):266-274. Doi: https://doi.org/10.1016/j.gie.2025.01.024
Kedar S, Chadha RM. Providing safe anesthetic care and sedation for GI endoscopy. Curr Anesthesiol Rep. 2024;14(2):161-171. Doi: https://doi.org/10.1007/s40140-024-00621-4
Steenholdt C, Jensen JT, Brynskov J, Møller AM, Limschou AC, Konge L, et al. Patient satisfaction of propofol versus midazolam and fentanyl sedation during colonoscopy in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2022;20(3):559-568. Doi: https://doi.org/10.1016/j.cgh.2020.10.037
Kudo T, Nishimoto S, Horiuchi I, Kurasawa S, Ukai S, Horiuchi A. Comparison of propofol?based sedation and midazolam sedation in pediatric bidirectional endoscopy conducted by pediatric gastroenterologists. DEN open. 2025;5(1):e391. Doi: https://doi.org/10.1002/deo2.391
Ahmer W, Imtiaz S, Alam DM, Ahmed K, Sajid B, Yousuf J, et al. Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2024;80(4):493-503. Doi: https://doi.org/10.1007/s00228-024-03624-6
Sidhu R, Turnbull D, Haboubi H, Leeds JS, Healey C, Hebbar S, et al. British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy. Gut. 2024;73(2):1-27. http://doi.org/ 10.1136/gutjnl-2023-330396
Park Y, Lee JK, Lee KH, Kim T, Kang SH, Ahn DW, Kim SB, Kim SJ. Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial. United European Gastroenterol J. 2026;14(1):e70147. Doi: https://doi.org/10.1002/ueg2.70147
Chen Y, Sun J, Lu Y, Fu L, Xiang X, Liu Y, et al. Efficacy and safety of midazolam combined with dezocine for sedation and analgesia in digestive endoscopy: A prospective open single-center study. Front Pharmacol. 2022;13:945597. Doi: https://doi.org/10.3389/fphar.2022.945597
Tringali A. Sedation and anesthesia in gastrointestinal endoscopy in 2025: how, who, and why. Gastrointest Endosc. 2026;103(3):438-450. Doi: https://doi.org/10.1016/j.gie.2025.09.014
Tsai HC, Lin YC, Ko CL, Lou HY, Chen TL, Tam KW, et al. Propofol versus midazolam for upper gastrointestinal endoscopy in cirrhotic patients: a meta-analysis of randomized controlled trials. PLoS One. 2015;10(2):e0117585. Doi:https://doi.org/10.1371/journal.pone.0117585
Wahab EA, Hamed EF, Ahmad HS, Abdel Monem SM, Fathy T. Conscious sedation using propofol versus midazolam in cirrhotic patients during upper GI endoscopy: A comparative study. JGH Open. 2019 ;3(1):25-31. https://doi.org/10.1002/jgh3.12098
Tabiri S, Adjimani NT, Mohammed BS. Propofol versus pethidine/midazolam sedation: benefits in flexible upper gastrointestinal endoscopy. Ain-Shams J Anesthesiol. 2018;10:1 https://doi.org/10.1186/s42077-018-0013-7
This work is licensed under a 